Kaye Mark 4

What Happened
Mark Kaye, a director of CONMED Corporation (CNMD), received a grant of 5,772 restricted stock units (RSUs) on 2026-06-01. The filing also shows that on 2026-06-02 Kaye converted/exercised 668 derivative units into shares and a matching 668 shares were reported as disposed the same day. All transactions show $0.00 per share and $0 total in the filing.

Key Details

• Transactions reported: 2026-06-01 (Grant/Award "A") — 5,772 RSUs acquired; 2026-06-02 (Exercise/Conversion "M") — 668 derivative shares acquired and 668 derivative shares disposed.
• Reported price/value: $0.00 per share; total value shown as $0 in the filing.
• RSU terms (footnotes): Each RSU is a contingent right to one common share under the Company’s 2025 Long-Term Incentive Plan; RSUs generally vest 100% after one year. (Footnotes F1/F2.)
• Shares owned after transaction: Not specified in the provided filing.
• Filing timing: Reported on SEC Form 4 filed 2026-06-03 covering activity through 2026-06-01/06-02 — no late filing flag shown in the information provided.

Context

• Code meanings: "A" = grant/award of derivative securities (RSUs); "M" = exercise or conversion of a derivative into underlying shares.
• Same-day conversion + disposition: The filing shows a conversion (exercise) of 668 units and a same-day disposition of 668 shares; the document does not state the reason for the disposition (e.g., tax withholding, sale to cover obligations, or other).
• For retail investors: Grants (RSUs) are compensation awards that vest over time and do not necessarily signal immediate insider sentiment. The zero dollar amounts reported reflect how the award/conversion was recorded on the Form 4, not the market value of CNMD stock.